Antibody-drug conjugates for precision oncology in cholangiocarcinoma

Authors

DOI:

https://doi.org/10.17179/excli2025-8952

Keywords:

ADCs, cholangiocarcinoma, Glypican-1, CD44v5, ICAM1, HER5, Trop-2

Downloads

Published

2025-11-14

How to Cite

Prasher, P., & Sharma, M. (2025). Antibody-drug conjugates for precision oncology in cholangiocarcinoma. EXCLI Journal, 24, 1594–1598. https://doi.org/10.17179/excli2025-8952

Issue

Section

Letters to the editor

Categories

Most read articles by the same author(s)